glp-1 review article Discovery of GLP-1–Based Drugs for the Treatment of Obesity The Role of Glucagon-Like Peptide-1

McGuire DK et al

Furthermore, Ozempic comes with several potential side effects, including nausea, fatigue, and more serious health risks like thyroid issues

They work through appetite and metabolic pathways, not by directly altering estrogen, progesterone, or testosterone levels

Obesity For weight loss, healthcare professionals may prescribe GLP-1 agonists for people with an initial BMI of 30 or higher or people who have a BMI of 27 or higher and at least one weight-related health condition, such as: type 2 diabetes prediabetes high blood pressure high cholesterol heart disease nonalcoholic fatty liver disease obstructive sleep apnea polycystic ovary syndrome Typically, healthcare professionals only prescribe these medications after someone has tried other weight loss methods, such as diet and exercise, without success